In previous studies, the applicant has demonstrated that basal levels of arginine vasopressin (AVP) mRNA are stable in adults and that secretion is tightly coupled to synthesis. In contrast, he found that in prepubertal rats (between weaning and sexual maturity) there is a progressive increase in both hypothalamic AVP mRNA and pituitary AVP. Accordingly, he hypothesizes that two dramatic changes in endocrine balance occurs in development to determine adult levels of AVP message and pituitary content: changes in sodium and fluid intake associated with weaning and onset of secretion of gonadal steroids. This proposal has 5 Specific Aims: 1. Quantify the dynamics of hypothalamic AVP mRNA and pituitary vasopressin content and identify the cellular mechanism(s) regulating AVP synthesis in the maturing rat. 2. In the young rat, determine the impact of osmotic manipulation on vasopressin synthesis and pituitary AVP accumulation and determine the site of regulation of these effects. 3. Determine the influence of gonadal steroids on AVP synthesis and the development of neurohypophyseal AVP stores in the immature rat. 4. Study the interaction of osmotic and steroidal inputs to the regulation of vasopressin synthesis and determine whether they are independent and additive, permissive, or synergistic. 5. Determine the long-term impact of osmotic and steroidal manipulations during the maturational period on vasopressin synthesis and neural lobe AVP content in the adult rat.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK016166-18
Application #
2136987
Study Section
Endocrinology Study Section (END)
Project Start
1977-01-01
Project End
1995-11-30
Budget Start
1993-12-06
Budget End
1994-11-30
Support Year
18
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Fitzsimmons, M D; Roberts, M M; Robinson, A G (1994) Control of posterior pituitary vasopressin content: implications for the regulation of the vasopressin gene. Endocrinology 134:1874-8
Lee, W S; Abbud, R; Hoffman, G E et al. (1993) Effects of N-methyl-D-aspartate receptor activation on cFos expression in luteinizing hormone-releasing hormone neurons in female rats. Endocrinology 133:2248-54
Roberts, M M; Robinson, A G; Fitzsimmons, M D et al. (1993) c-fos expression in vasopressin and oxytocin neurons reveals functional heterogeneity within magnocellular neurons. Neuroendocrinology 57:388-400
Fitzsimmons, M D; Roberts, M M; Sherman, T G et al. (1992) Models of neurohypophyseal homeostasis. Am J Physiol 262:R1121-30
Mitrakou, A; Vuorinen-Markkola, H; Raptis, G et al. (1992) Simultaneous assessment of insulin secretion and insulin sensitivity using a hyperglycemia clamp. J Clin Endocrinol Metab 75:379-82
Dohanics, J; Hoffman, G E; Verbalis, J G (1991) Hyponatremia-induced inhibition of magnocellular neurons causes stressor-selective impairment of stimulated adrenocorticotropin secretion in rats. Endocrinology 128:331-40
Lee, W S; Smith, M S; Hoffman, G E (1990) Progesterone enhances the surge of luteinizing hormone by increasing the activation of luteinizing hormone-releasing hormone neurons. Endocrinology 127:2604-6
Hoffman, G E; Lee, W S; Attardi, B et al. (1990) Luteinizing hormone-releasing hormone neurons express c-fos antigen after steroid activation. Endocrinology 126:1736-41
Robinson, A G; Roberts, M M; Evron, W A et al. (1989) Total translation of vasopressin and oxytocin in neurohypophysis of rats. Am J Physiol 257:R109-17